IMIDomics
IMIDomics is an emerging global enterprise which combines exclusive access to data with biological insights that will lead to the discovery, targeting, and development of medicines for immune-mediated inflammatory diseases.
Private Company
Total funding raised: $23M
About
IMIDomics is an emerging global enterprise which combines exclusive access to data with biological insights that will lead to the discovery, targeting, and development of medicines for immune-mediated inflammatory diseases.
ImmunologyGenetics & Genomics
Funding History
2Total raised:$23M
Series A$18M
Seed$5M